Literature DB >> 2993003

Human embryonal carcinoma cells express low levels of functional receptor for epidermal growth factor.

C R Carlin, P W Andrews.   

Abstract

Using immunological probes, we have detected expression of the receptor for epidermal growth factor (EGF) at the cell surface of the clonally-derived human embryonal carcinoma (EC) cell lines, 2102Ep cl. 4D3 and NTERA-2 cl. D1. By this method, the level of receptor expression by these cells is estimated to be 3- to 5-fold less than for the human diploid fibroblast cell line, WI38, and our results indicate that it is the EC stem cells that display this receptor and not a subpopulation of differentiated cells. The human EC cell receptor binds ligand and catalyses autophosphorylation at tyrosine in a normal fashion. Treatment of NTERA-2 cl. D1 cells with retinoic acid (RA) for 7 days to induce differentiation results in decreased levels of receptor expression, and a subpopulation of differentiated cells possessing a markedly higher level of the EGF receptor was not detected among the cultures exposed to RA for longer periods.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993003     DOI: 10.1016/s0014-4827(85)80033-1

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  4 in total

1.  Secretion of polypeptides related to epidermal growth factor and insulinlike growth factor I by a human teratocarcinoma cell line.

Authors:  N H Jing; R Shiurba; H Kitani; H Kawakatsu; Y Tomooka; T Sakakura
Journal:  In Vitro Cell Dev Biol       Date:  1991-11

2.  Growth requirements, growth factor responsiveness, and growth factor secretion of three human embryonal carcinoma cell lines.

Authors:  W Verbeek; C Bokemeyer; H Falk; H J Schmoll
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

3.  Biosynthesis and glycosylation of the epidermal growth factor receptor in human tumor-derived cell lines A431 and Hep 3B.

Authors:  C R Carlin; B B Knowles
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

4.  β-Arrestin1 and distinct CXCR4 structures are required for stromal derived factor-1 to downregulate CXCR4 cell-surface levels in neuroblastoma.

Authors:  Ian C Clift; Adebowale O Bamidele; Christie Rodriguez-Ramirez; Kimberly N Kremer; Karen E Hedin
Journal:  Mol Pharmacol       Date:  2014-01-22       Impact factor: 4.436

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.